Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laura A Williams Insider Profile
4 Followers
Laura A Williams, Director at Enliven Therapeutics, holds ― shares in Enliven Therapeutics (Ticker: ELVN), holds 322.15K shares in Ardelyx (Ticker: ARDX). Most recently, Laura A Williams ― shares of Enliven Therapeutics on ― for an estimated value of ―.
Profitable Transactions
2 out of 8 Profitable Transactions
Average Return
-89.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Laura A Williams
Laura A Williams's Trading History
Enliven Therapeutics
―
Director
―
―
Ardelyx
Jun 07, 2024
CMO
Uninformative Buy
275.00K
$1.78M
List of latest transactions for each holding click on a transaction to see Laura A Williams's performance on stock
You May Also Like
Laura A Williams insider profile FAQ
What is the percentage of profitable transactions made by Laura A Williams?
The percentage of profitable transactions made by Laura A Williams is 25%.
What is the average return per transaction made by Laura A Williams?
The average return per transaction made by Laura A Williams is -89.90%.
What stocks does Laura A Williams hold?
Laura A Williams holds: ELVN, ARDX stocks.
What was Laura A Williams’s latest transaction?
Laura A Williams latest transaction was an Uninformative Buy of ―.
What was Laura A Williams's most profitable transaction?
Laura A Williams’s most profitable transaction was an Informative Sell of ARDX stock on February 22, 2024. The return on the trade was 37.50%.
What is Laura A Williams's role in Enliven Therapeutics?
Laura A Williams's role in Enliven Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.